Opioid Misuse Among American Indian Adolescents.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 33476235.
- Also identified by DOI 10.2105/AJPH.2020.306039 and PMC identifier 7893342.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
<b>Objectives.</b> To present data for opioid misuse among US reservation-based American Indian (AI) adolescents and to compare these data with national rates from Monitoring the Future (MTF).<b>Methods.</b> Data were from a national sample of 33 schools participating in a substance use epidemiological survey of reservation-based AI adolescents during 2018 and 2019. Participants were 8th-, 10th-, and 12th-grade AI students (n = 1592). Measures included 12-month and 30-day use of OxyContin, Vicodin, heroin, and narcotics. We computed prevalence and compared it with MTF national prevalence.<b>Results.</b> Across grades, AI youths demonstrated significantly greater past 12-month and 30-day opioid use relative to a national sample. Significant absolute differences in 12-month and 30-day prevalence levels ranged from 1.6% (8th-grade heroin) to 4.7% (12th-grade narcotics) and from 1.6% (12th-grade narcotics) to 1.8% (12th-grade heroin), respectively.<b>Conclusions.</b> Opioid misuse prevalence levels were significantly greater for reservation-based AI adolescents relative to national prevalence levels.<b>Public Health Implications.</b> Findings suggest that implementation of evidence-based efforts, adapted or developed to be culturally appropriate, should be significantly increased in tribal communities, along with policies to address the unique social, economic, and health issues they face.
Medical subject headings
- Acetaminophen
- Adolescent Behavior
- Hydrocodone
- Indians, North American
- Opioid-Related Disorders
- Students